LGBTQ Loyalty (LFAP) 10-Q 9 Dec 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Dec. 09, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-54867
Entity Registrant Name	LGBTQ LOYALTY HOLDINGS, INC.
Entity Central Index Key	0001510247
Entity Tax Identification Number	80-0671280
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2435 Dixie Highway
Entity Address, City or Town	Wilton Manors
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33305
City Area Code	(858)
Local Phone Number	577-1746
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,179,890,617

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 9,387	$ 78,348
Prepaid expenses and other current assets	8,270	6,925
Total current assets	17,657	85,273
Intangible assets, net	33,899	53,243
Total assets	51,556	138,516
Current liabilities:
Accounts payable	1,549,593	985,917
Accrued salaries and consulting fees	743,321	660,331
Accrued interest and dividends	948,604	640,153
Notes payable	256,986	126,986
Notes payable to related party	71,800	1,800
Convertible notes payable, net of debt discount	2,415,028	2,195,145
Derivative liability on convertible notes payable	3,036,614	1,398,127
Series D preferred stock	1,758,224
Total liabilities	10,780,170	6,008,459
Commitments and contingencies
Stockholders’ equity (deficit):
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 1,244,213,365 and 832,719,287 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	1,244,213	832,719
Additional paid-in capital	12,549,666	13,215,129
Accumulated deficit	(24,522,546)	(19,917,844)
Total stockholders’ equity (deficit)	(10,728,614)	(5,869,943)
Total liabilities and stockholders’ equity (deficit)	51,556	138,516
Series A Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock
Series B Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock
Series C Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock	52	52
Series D Preferred Stock [Member]
Stockholders’ equity (deficit):
Preferred stock	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, shares issued	1,244,213,365	832,719,287
Common stock, shares outstanding	1,244,213,365	832,719,287
Series A Preferred Stock [Member]
Preferred stock, shares authorized	1	1
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	50,000
Preferred stock, shares outstanding	0	50,000
Series C Preferred Stock [Member]
Preferred stock, shares authorized	129,559	129,559
Preferred stock, shares issued	52,559	0
Preferred stock, shares outstanding	52,559	0
Series D Preferred Stock [Member]
Preferred stock, shares authorized	2,000	2,000
Preferred stock, shares issued	986	1,050
Preferred stock, shares outstanding	986	1,050

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue
Cost of net revenue
Gross profit
Operating expenses:
Personnel costs	27,852	132,097	188,253	1,521,218
Consulting fees	11,250	2,220	37,750	73,720
Legal and professional fees	78,245	308,382	360,030	567,032
Fund expenses			100,000
Sales and marketing	21,036	117,012	119,975	157,512
General and administrative	12,921	30,727	64,266	87,241
Depreciation and amortization	6,448	6,448	19,344	19,344
Total operating expenses	157,752	596,886	889,618	2,426,067
Loss from operations	(157,752)	(596,886)	(889,618)	(2,426,067)
Other expense:
Interest expense	(149,439)	(437,528)	(1,675,189)	(1,726,856)
Other income (expense)		(7,076)		(7,076)
Change in derivative liability	(318,536)	1,422,551	(1,471,760)	(823,425)
Total other expense	(467,975)	977,947	(3,146,949)	(2,557,357)
Provision for income taxes
Net income (loss)	$ (625,727)	$ 381,062	$ (4,036,567)	$ (4,983,424)
Weighted average common shares outstanding - basic and diluted	1,218,194,847	553,901,386	1,032,011,912	650,976,730
Net income (loss) per common share - basic and diluted	$ (0.001)	$ 0	$ (0.004)	$ (0.01)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (4,036,567)	$ (4,983,424)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and original issue discount	158,690	1,077,708
Change in fair value of derivative liability	1,471,760	823,425
Financing related costs - debt	1,220,986	460,780
Stock-based compensation expense		1,218,114
Depreciation and amortization	19,344	19,344
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(1,345)	(12,058)
Accounts payable	551,600	(54,428)
Accrued salaries and consulting fees	82,990	223,279
Accrued interest and dividends	263,581	141,132
Net cash used in operating activities	(268,961)	(1,086,128)
Cash flows from investing activities:
Purchases of property and equipment
Other receivables		(205,000)
Net cash used in investing activities		(205,000)
Cash flows from financing activities:
Net proceeds (repayments) from promissory note agreements	200,000	(1,000)
Proceeds from issuance of convertible debenture agreements		300,000
Repayments of convertible debt agreements		(56,350)
Proceeds from issuance of common stock under equity line of credit		78,620
Proceeds from issuance of Series D preferred stock		1,061,600
Net cash provided by financing activities	200,000	1,382,870
Net change in cash	(68,961)	91,741
Cash at beginning of period	78,348	30,312
Cash at end of period	9,387	122,053
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest		4,944
Supplemental disclosure of non-cash financing activities:
Exercise of common stock warrants	140,966
Dividends on preferred stock	44,870	30,866
Conversion of Series D preferred stock for common stock	111,000
Deemed dividend on conversion of preferred stock	523,266
Debenture conversions	238,764
Reclassification of Series D preferred stock	1,015,999
Conversion of accrued consulting fees into common shares		338,608
Conversion of related party notes payable into common shares		16,085
Conversion of Series C preferred stock into common stock		$ 78,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Preferred Stock [Member] Series C Preferred Stock [Member]	Preferred Stock [Member] Series D Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2020		$ 50	$ 130		$ 263,725	$ 7,714,704	$ (13,239,189)	$ (5,260,580)
Begning balance, shares at Dec. 31, 2020		50,000	129,559		263,725,234
Common shares issued to board of directors					$ 140,000	980,000		1,120,000
Common shares issued to board of directors, shares					140,000,000
Common shares issued for services and compensation					$ 31,834	204,614		236,448
Common shares issued for services, shares					31,834,386
Debenture conversions					$ 37,539	318,815		356,354
Debenture conversions, shares					37,538,998
Dividends on preferred stock							(1,722)	(1,722)
Net loss							(1,617,405)	(1,617,405)
Balance at Mar. 31, 2021		$ 50	$ 130		$ 473,098	9,218,133	(14,858,316)	(5,166,906)
Ending balance, shares at Mar. 31, 2021		50,000	129,559		473,098,618
Balance at Dec. 31, 2020		$ 50	$ 130		$ 263,725	7,714,704	(13,239,189)	(5,260,580)
Begning balance, shares at Dec. 31, 2020		50,000	129,559		263,725,234
Balance at Jun. 30, 2021		$ 50	$ 77		$ 669,390	11,147,767	(18,614,915)	(6,797,631)
Ending balance, shares at Jun. 30, 2021		50,000	76,559		669,390,677
Balance at Dec. 31, 2020		$ 50	$ 130		$ 263,725	7,714,704	(13,239,189)	(5,260,580)
Begning balance, shares at Dec. 31, 2020		50,000	129,559		263,725,234
Balance at Dec. 31, 2021			$ 52	$ 1	$ 832,719	13,215,129	(19,917,844)	(5,869,943)
Ending balance, shares at Dec. 31, 2021			51,559	1,050	832,719,287
Balance at Mar. 31, 2021		$ 50	$ 130		$ 473,098	9,218,133	(14,858,316)	(5,166,906)
Begning balance, shares at Mar. 31, 2021		50,000	129,559		473,098,618
Dividends on preferred stock							(9,519)	(9,519)
Net loss							(3,747,079)	(3,747,079)
Debenture conversions					$ 100,449	1,821,061		1,921,510
Debenture conversions, shares					100,448,779
Conversion of notes and payables					$ 11,956	192,408		204,364
Conversion of notes and payables, shares					11,956,004
Exercise of warrants					$ 30,887	(30,887)
Exercise of warrants, shares					30,887,276
Conversion of Series D preferred stock for common stock			$ (53)		$ 53,000	(52,947)
Conversion of Series D preferred stock for common stock, shares			(53,000)		53,000,000
Balance at Jun. 30, 2021		$ 50	$ 77		$ 669,390	11,147,767	(18,614,915)	(6,797,631)
Ending balance, shares at Jun. 30, 2021		50,000	76,559		669,390,677
Common shares issued for services, shares					13,440,860
Dividends on preferred stock							(19,625)	(19,625)
Net loss							381,060	381,060
Debenture conversions					$ 20,480	304,123		324,603
Debenture conversions, shares					20,479,798
Exercise of warrants					$ 30,887	(30,887)
Exercise of warrants, shares					30,887,275
Conversion of Series D preferred stock for common stock			$ (25)		$ 25,000	(24,975)
Conversion of Series D preferred stock for common stock, shares			(25,000)		25,000,000
Common shares issued pursuant to equity line of credit					$ 13,387	72,309		85,696
Common shares issued pursuant to equity line of credit, shares					13,386,862
Common shares issued for services					$ 13,441	111,559		125,000
Conversion of Series B preferred stock for common shares		$ (25)			$ 958	(933)
Conversion of Series B preferred stock for common shares, shares		(25,000)			958,333
Issuance of Series B dividend common shares					$ 461	6,439		6,900
Issuance of Series B dividend common shares, shares					461,395
Balance at Sep. 30, 2021		$ 25	$ 52		$ 774,004	11,585,402	(18,253,480)	(5,893,997)
Ending balance, shares at Sep. 30, 2021		25,000	51,559		774,005,200
Balance at Dec. 31, 2021			$ 52	$ 1	$ 832,719	13,215,129	(19,917,844)	(5,869,943)
Begning balance, shares at Dec. 31, 2021			51,559	1,050	832,719,287
Dividends on preferred stock							(22,720)	(22,720)
Net loss							(921,819)	(921,819)
Exercise of warrants					$ 43,349	(43,349)
Exercise of warrants, shares					43,349,000
Conversion of Series D preferred stock for common stock					$ 36,000	(36,000)
Conversion of Series D preferred stock for common stock, shares				(45)	36,000,000
Deemed dividend on conversion of preferred stock						237,924	(237,924)
Balance at Mar. 31, 2022			$ 52	$ 1	$ 912,068	13,373,704	(21,100,307)	(6,814,482)
Ending balance, shares at Mar. 31, 2022			51,559	1,005	912,068,287
Debenture conversions					$ 84,325	42,236		126,561
Debenture conversions, shares					84,325,397
Dividends on preferred stock							(22,150)	(22,150)
Net loss							(2,489,020)	(2,489,020)
Exercise of warrants					$ 97,617	(97,617)
Exercise of warrants, shares					97,617,300
Conversion of Series D preferred stock for common stock					$ 38,000	(38,000)
Conversion of Series D preferred stock for common stock, shares				(19)	38,000,000
Deemed dividend on conversion of preferred stock						285,342	(285,342)
Reclassification of Series D preferred stock						(1,015,999)		(1,015,999)
Balance at Jun. 30, 2022			$ 52	$ 1	$ 1,132,011	12,549,666	(23,896,819)	(10,215,094)
Ending balance, shares at Jun. 30, 2022			51,559	986	1,132,010,984
Net loss							(625,727)	(625,727)
Debenture conversions					$ 112,202			112,202
Debenture conversions, shares					112,202,381
Balance at Sep. 30, 2022			$ 52	$ 1	$ 1,244,213	$ 12,549,666	$ (24,522,546)	$ (10,728,614)
Ending balance, shares at Sep. 30, 2022			51,559	986	1,244,213,365

Nature of Business

Nature of Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Note 1. Nature of Business Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to LGBTQ Loyalty Holdings, Inc. (formerly LifeApps Brands Inc.), including its subsidiaries. On January 25, 2019, we acquired LGBT Loyalty LLC, a New York limited liability company, with the goal of creating the first LGBTQ Loyalty Preference Index ETF (the “Index ETF”) to provide the LGBTQ community with the power to influence the allocation of capital within a financial Index ETF based upon LGBTQ consumer preferences. The Index ETF was intended to link the growing economic influence of the LGBTQ community and their allies with many of the top Fortune 500 companies that support and implement diversity, inclusion and equality policies within their organizations. The incorporation of diversity and inclusion in a company’s recruitment and human resource policies has become a key concern to investors as part of their growing focus on ESG allocations. Our data and analytics unequivocally reinforce that corporations that have embraced diversity and inclusion policies within their corporate culture perform at a higher level financially than their peers. This includes advancing a more invigorated workforce that attracts and retains the best talent. Innovation and agility have been identified as great benefits of diversity, and there is an increasing awareness of what has become known as ‘the power of difference’. On October 30, 2019, through our wholly-owned subsidiary Loyalty Preference Index, Inc. (“LPI”) and our strategically aligned partnerships with crowd-sourced data and analytic providers, we launched the LGBTQ100 ESG Index. This Index integrates LGBTQ community survey data into the methodology for a benchmark listing of the nation’s highest financially performing large-cap publicly listed corporations that our respondents believe are most committed to advancing equality. LPI is the index provider for the LGBTQ + ESG100 ETF; LGBTQ Loyalty was the Sponsor for the prospectus that was filed by the licensed Fund Adviser ProcureAM, and was approved by the Securities and Exchange Commission (“SEC”) in early January 2020. The LGBTQ + ESG100 ETF (the “Fund”) sought to track the investment results (before fees and expenses) of the LGBTQ100 ESG Index. In late 2020, LPI was renamed to Advancing Equality Preference, Inc. On March 25, 2022, ProcureAM, LLC (“Adviser”), the adviser to the Fund, after consultation with the Company, the sponsor of the ETF, determined that the Fund should be closed. Based upon a recommendation by the Adviser, the Board of Trustees of Procure ETF Trust I (the “Trust”) approved a Plan of Liquidation for the Fund under which the Fund would be liquidated on or about April 28, 2022 (the “Liquidation Date”). The Liquidation Date may be changed without notice at the discretion of the officers of the Trust. Beginning when the Fund commences the liquidation of its portfolio, the Fund will not pursue its investment objectives or, with certain exceptions, engage in normal business activities, and the Fund may hold cash and securities that may not be consistent with the Fund’s investment objective and strategy, which may adversely affect Fund performance. On April 28, 2022, the Company effectuated the termination and liquidation of the Fund pursuant to the terms of a Plan of Liquidation. As of this date, the Fund has ceased operations.

Correction of Previously Issued

Correction of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Correction of Previously Issued Financial Statements	Note 2. Correction of Previously Issued Financial Statements Subsequent to the issuance of its Quarterly Report on SEC Form 10-Q for the three and six months ended September 30, 2022, the Company discovered several errors in its accounts on its condensed consolidated balance sheets and statements of operations. The tables below reflect the effect of restatement on the Company’s financial statements for the three and six month periods ending June 30, 2022: Schedule of Restatement of Company’s Financial Statements Original Adjustment As Restated June 30, 2022 Original Adjustment As Restated Cash $ 11,269 $ 1,665 $ 12,934 Total assets $ 59,886 $ 1,665 $ 61,551 Accounts payable $ 1,386,797 $ 21,979 $ 1,408,776 Accrued salaries and consulting fees 743,321 (20,314 ) 723,007 Derivative liability on convertible notes payable 2,769,066 12,369 2,781,435 Total liabilities 10,262,606 14,034 10,276,640 Common stock 1,132,007 3 1,132,010 Additional paid-in capital 12,549,666 1 12,549,667 Accumulated deficit (23,884,446 ) (12,373 ) (23,896,819 ) Total stockholders’ equity (deficit) (10,202,720 ) (12,369 ) (10,215,089 ) Total liabilities and stockholders’ equity (deficit) $ 59,886 $ 1,665 $ 61,551 Original Adjustment As Restated Six months Ended June 30, 2022 Original Adjustment As Restated General and administrative $ 39,453 $ 11,892 $ 51,345 Total operating expenses 719,974 11,892 731,866 Interest expense (1,525,116 ) (634 ) (1,525,750 ) Change in derivative liability (1,105,465 ) (47,759 ) (1,153,224 ) Net loss $ (3,350,555 ) $ (60,285 ) $ (3,410,840 ) Original Adjustment As Restated Six months Ended June 30, 2022 Original Adjustment As Restated Net cash used in operating activities $ (237,079 ) $ 1,665 $ (235,414 ) Original Adjustment As Restated Three Months Ended Sep June 30, 2022 Original Adjustment As Restated Debenture conversions $ 114,040 $ 12,522 $ 126,562

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3. Summary of Significant Accounting Policies Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“US GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $ 24,522,546 10,762,513 Basis of Presentation We have prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These condensed consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of our balance sheets, operating results, and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for fiscal year 2022. Certain information and footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with US GAAP have been omitted in accordance with the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC. The unaudited condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP. Prior Period Adjustments In the first quarter of 2022, we determined that the Series D preferred stock included a substantive conversion option, and therefore should be equity classified. Previously, the amount was included as a current liability. We have reclassified the amount to Series D preferred stock equity and additional paid-in capital on the consolidated balance sheet and consolidated statement of stockholders’ equity as of December 31, 2021. We do not believe the change to be qualitatively material to the consolidated financial statements as of December 31, 2021. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, and Advancing Equality Preference, Inc. All material inter-company transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is measured as a Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Schedule of Financial Instruments at Fair Value Fair Value Measurements as of September 30, 2022: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable and preferred stock $ - $ - $ 3,036,614 $ 3,036,614 $ - $ - $ 3,036,614 $ 3,036,614 Fair Value Measurements as of December 31, 2021: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,398,127 $ 1,398,127 $ - $ - $ 1,398,127 $ 1,398,127 Refer to Note 7 for detail on the unobservable inputs used in the fair value of the derivative liability. Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Schedule of Anti-dilutive Securities Excluded from Diluted Net Loss 2022 2021 Nine Months Ended September 30, 2022 2021 Stock options outstanding - 1,800,000 Warrants 28,333,333 204,946,057 Shares to be issued upon conversion of notes 9,726,808,810 203,651,096 Series D preferred stock 2,010,000,000 67,826 Anti-dilutive securities 11,765,142,143 410,464,979 Recent Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, which simplifies the guidance on the issuer’s accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt and will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that is within the scope of ASU 2020-06. ASU 2020-06 is applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company has elected to early adopt this ASU in the first quarter of 2022 and the adoption of this ASU did not have a material impact on the Company’s consolidated financial statements and related disclosures. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4. Intangible Assets The Company capitalizes costs pertaining to the development of the LGBTQ100 ESG Index website. The Company began amortizing these costs upon the launch of the index, and will amortize the costs over a three-year useful life. At September 30, 2022 and December 31, 2021, net intangible assets were $ 33,899 53,243 19,344

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes Payable	Note 5. Notes Payable As of September 30, 2022 and December 31, 2021, the Company has a note payable outstanding in the amount of $ 1,986 2 In December 2019, the Company issued a promissory note to Pride Partners LLC (“Pride”) for $ 75,000 10 In 2019, the Company issued a promissory note for $ 50,000 2,500 In April 2022, Advancing Equality Preference entered into a loan payable for $ 130,000 100,000

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 6. Convertible Notes Payable During the nine months ended September 30, 2022 and 2021, the Company recorded amortization of debt discount and original issue discount of $ 158,690 1,077,708 The Company did not file its Form 10-Q for the quarter ended March 31, 2022 on a timely basis. As a result, several default provisions were triggered with the Company’s outstanding debentures. The Company recorded an additional $ 374,125 374,125 The following is a summary of the activity of the convertible notes payable and convertible debenture for the nine months ended September 30, 2022: Schedule of Convertible Notes Payable and Convertible Debentures Activity Convertible Debenture Balance as of December 31, 2021 $ 2,195,145 Convertible debenture - debt discount (213,932 ) Additional principal per default provisions 374,125 Amortization of debt discount and original issue discount 158,690 Conversion to common stock, net of discount (99,000 ) Balance as of September 30, 2022 $ 2,415,028 The following comprises the balance of the convertible debenture outstanding at September 30, 2022 and December 31, 2021: Schedule of Convertible Debenture Outstanding September 30, December 31, 2022 2021 Principal amount outstanding $ 2,496,152 $ 2,221,027 Less: Unamortized original issue discount (79,962 ) - Less: Unamortized original issue discount (1,162 ) (25,882 ) Total $ 2,415,028 $ 2,195,145 As of September 30, 2022 and December 31, 2021, the EMA Note was in default and the parity value of the EMA Note was determined to be $ 434,687 60,714,000

Derivative Liability

Derivative Liability	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	Note 7. Derivative Liability We evaluated the terms of the conversion features of the debentures and related debenture warrants as noted above and below, in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock To determine the fair value of our embedded derivatives, management evaluates assumptions regarding the probability of certain future events. Other factors used to determine fair value include our period end stock price, historical stock volatility, risk free interest rate and derivative term. The fair value recorded for the derivative liability varies from period to period. This variability may result in the actual derivative liability for a period either above or below the estimates recorded on our consolidated financial statements, resulting in significant fluctuations in other income (expense) because of the corresponding non-cash gain or loss recorded. We value the conversion feature at origination of the notes using the Black-Scholes valuation model with the below assumptions. We value the derivative liability at the end of each accounting period, and upon conversion of the underlying note or warrant, with the difference in value recognized as gain or loss included in other income (expense) in our consolidated statements of operations. Schedule of Conversion Feature of Derivative Liability Nine months Ended September 30, 2022 2021 Risk-free interest rate 2.01 % 0.09 % Expected term (in years) 0.48 1 Expected volatility 154.5 % 237.4 % Expected dividend yield 0 % 0 % Exercise price of underlying common shares $ 0.001 $ 0.004 During the nine months ended September 30, 2022, the entire value of the principal of the debentures was assigned to the derivative liability and recognized as a debt discount. The debt discount is recorded as reduction (contra-liability) to the debentures and is being amortized over the initial term. Any excess balance was recognized as origination interest on the derivative liability and expensed on origination. The following is a summary of the activity of the derivative liability for the nine months ended September 30, 2022: Schedule of Derivative Liability Activity Debenture Balance as of December 31, 2021 $ 1,398,127 Initial fair value per derivative recognition 294,124 Conversion of debenture to common stock (127,397 ) Change in fair value of derivative liability 1,471,760 Balance as of September 30, 2022 $ 3,036,614

Preferred Stock

Preferred Stock	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Preferred Stock	Note 8. Preferred Stock Series D Convertible Preferred Stock On April 8, 2021, the Company issued 400 GHS Investments, LLC (“ GHS”) pursuant to a Securities Purchase Agreement (“GHS April Agreement”) for net proceeds of $ 427,600 40,000,000 0.001 On May 12, 2021, the Company issued 150 146,500 1,500,000 0.001 Notwithstanding, on June 23, 2021, GHS and the Company entered into a Rescission Agreement (the “Rescission Agreement”) pursuant to which the Company and GHS agreed to rescind, ab initio, the issuances of Warrants to GHS. Pursuant to the Rescission Agreement, GHS and the Company agreed that the issuance of the Warrants are unconditionally and irrevocably rescinded ab initio by GHS and the Company, and the Warrants are neither valid nor effective in any manner whatsoever. Further, GHS and the Company acknowledged that each has been restored to the position in which such party found itself on the date that the respective GHS Agreement was executed but without any references, rights or obligations relative to the Warrants contained in, or otherwise granted in, either the GHS Agreements or the Warrants. As a result, GHS has no rights whatsoever to the Warrants and the Company has no rights whatsoever to the any exercise price that it may have received pursuant to the Warrants. In connection with the execution and delivery of the Rescission Agreement, the Company and GHS entered into two (2) Amended and Restated Purchase Agreements which each seek to amend and restate the terms and conditions contained in the April Agreement and the May Agreement. On July 14, 2021, the Company issued 250 237,500 250 250,000 On the one-year anniversary of the date of issuance of the Preferred Stock, the Company must redeem the Preferred Stock then outstanding at a price equal to the outstanding Stated Value together with any accrued but unpaid dividends. In January 2022, GHS converted 45 54,000 36,000,000 0.0015 237,924 0.0015 0.008109 In June 2022, GHS converted 19 22,800 38,000,000 0.0006 285,342 0.0006 0.008109 As of September 30, 2022, there were 986 97,814 1,050 52,944 Due to the Company’s late filing on its Form 10-Q for the quarter ended March 31, 2022 (see Note 7), default provisions were triggered with the GHS agreement. As a result, it was determined all preferred stock were due for redemption immediately. The Company determined that $ 1,758,224 1,015,999 644,411

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders’ Equity (Deficit)	Note 9. Stockholders’ Equity (Deficit) Common Stock In January 2022, GHS converted 45 54,000 36,000,000 0.0015 In June 2022, GHS converted 19 57,000 38,000,000 0.0006 In the nine months ended September 30, 2022, Auctus exercised warrants for 140,966,300 In March 2021, an aggregate of 140,000,000 961,666 In March 2021, an aggregate of 31,834,386 236,448 In June 2021, an aggregate of 11,956,004 204,364 In June 2021, Auctus exercised 32,142,857 During the nine months ended September 30, 2021, Pride converted 53,000 53,000,000 During the nine months ended September 30, 2022 and 2021, the Company issued 196,527,778 137,987,777 99,000 495,247

Options and Warrants

Options and Warrants	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Options and Warrants	Note 10. Options and Warrants Options As of September 30, 2022 and December 31, 2021, we had 0 Warrants As of September 30, 2022 and December 31, 2021, we had 28,333,333 174,058,782 0.01 0.02 140,966,300

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 11. Related Party Transactions Parties, which can be a corporation or an individual, are considered to be related if we have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Notes Payable to Related Party Notes payable to related parties at September 30, 2022 and December 31, 2021 included a note of $ 1,800 2 In February 2022, the Company issued a promissory note to a related party for $ 70,000 Accrued Salaries and Compensation As of September 30, 2022 and December 31, 2021, accrued salaries to our company officers and executive director totaled $ 522,804 472,804 In March 2021, we issued 200,000,000 160,000 Board of Directors In March 2021, we issued 20,000,000 140,000,000 961,666 138,334 A former board member is the co-founder and president of ProcureAM, LLC, the fund advisor for the Fund. During 2021, we initially received $ 100,000 305,000 305,000 100,000 0 On April 15, 2022, Deborah Fuhr submitted her resignation as a member of the Board, effective immediately. Ms. Fuhr submitted her resignation to pursue other interests. The Company’s Board accepted Ms. Fuhr’s resignation and expressed its appreciation for the services she provided to the Company. On August 25, 2022, Barney Frank and Martina Navratilova submitted their resignations as Directors of LGBTQ Loyalty Holdings, Inc. (the “Company”) with immediate effect. Additionally, on August 27, 2022, William Bean submitted his resignation as a Director of the Company with immediate effect. Mr. Frank and Mr. Bean submitted their resignations due to differences of opinion in the direction of the Company. Each of Messrs. Frank and Bean and Ms. Navratilova have offered to tender their respective shares of Common Stock back to the Company. Accounts Payable As of September 30, 2022 and December 31, 2021, the Company had $ 168,308 102,808

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events Management has evaluated all activity up to December 9, 2022 and concluded that no subsequent events have occurred that would require recognition in these financial statements or disclosure in the notes to these financial statements other than the following: On October 5, 2022, former members of the Board tendered 64,322,748

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Going Concern	Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“US GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $ 24,522,546 10,762,513
Basis of Presentation	Basis of Presentation We have prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These condensed consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of our balance sheets, operating results, and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for fiscal year 2022. Certain information and footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with US GAAP have been omitted in accordance with the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC. The unaudited condensed consolidated balance sheet as of December 31, 2021 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.
Prior Period Adjustments	Prior Period Adjustments In the first quarter of 2022, we determined that the Series D preferred stock included a substantive conversion option, and therefore should be equity classified. Previously, the amount was included as a current liability. We have reclassified the amount to Series D preferred stock equity and additional paid-in capital on the consolidated balance sheet and consolidated statement of stockholders’ equity as of December 31, 2021. We do not believe the change to be qualitatively material to the consolidated financial statements as of December 31, 2021.
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, and Advancing Equality Preference, Inc. All material inter-company transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
Fair Value Measurements	Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is measured as a Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Schedule of Financial Instruments at Fair Value Fair Value Measurements as of September 30, 2022: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable and preferred stock $ - $ - $ 3,036,614 $ 3,036,614 $ - $ - $ 3,036,614 $ 3,036,614 Fair Value Measurements as of December 31, 2021: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,398,127 $ 1,398,127 $ - $ - $ 1,398,127 $ 1,398,127 Refer to Note 7 for detail on the unobservable inputs used in the fair value of the derivative liability.
Earnings per Share	Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Schedule of Anti-dilutive Securities Excluded from Diluted Net Loss 2022 2021 Nine Months Ended September 30, 2022 2021 Stock options outstanding - 1,800,000 Warrants 28,333,333 204,946,057 Shares to be issued upon conversion of notes 9,726,808,810 203,651,096 Series D preferred stock 2,010,000,000 67,826 Anti-dilutive securities 11,765,142,143 410,464,979
Recent Pronouncements	Recent Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, which simplifies the guidance on the issuer’s accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt and will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that is within the scope of ASU 2020-06. ASU 2020-06 is applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company has elected to early adopt this ASU in the first quarter of 2022 and the adoption of this ASU did not have a material impact on the Company’s consolidated financial statements and related disclosures. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Correction of Previously Issu_2

Correction of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Schedule of Restatement of Company’s Financial Statements	The tables below reflect the effect of restatement on the Company’s financial statements for the three and six month periods ending June 30, 2022: Schedule of Restatement of Company’s Financial Statements Original Adjustment As Restated June 30, 2022 Original Adjustment As Restated Cash $ 11,269 $ 1,665 $ 12,934 Total assets $ 59,886 $ 1,665 $ 61,551 Accounts payable $ 1,386,797 $ 21,979 $ 1,408,776 Accrued salaries and consulting fees 743,321 (20,314 ) 723,007 Derivative liability on convertible notes payable 2,769,066 12,369 2,781,435 Total liabilities 10,262,606 14,034 10,276,640 Common stock 1,132,007 3 1,132,010 Additional paid-in capital 12,549,666 1 12,549,667 Accumulated deficit (23,884,446 ) (12,373 ) (23,896,819 ) Total stockholders’ equity (deficit) (10,202,720 ) (12,369 ) (10,215,089 ) Total liabilities and stockholders’ equity (deficit) $ 59,886 $ 1,665 $ 61,551 Original Adjustment As Restated Six months Ended June 30, 2022 Original Adjustment As Restated General and administrative $ 39,453 $ 11,892 $ 51,345 Total operating expenses 719,974 11,892 731,866 Interest expense (1,525,116 ) (634 ) (1,525,750 ) Change in derivative liability (1,105,465 ) (47,759 ) (1,153,224 ) Net loss $ (3,350,555 ) $ (60,285 ) $ (3,410,840 ) Original Adjustment As Restated Six months Ended June 30, 2022 Original Adjustment As Restated Net cash used in operating activities $ (237,079 ) $ 1,665 $ (235,414 ) Original Adjustment As Restated Three Months Ended Sep June 30, 2022 Original Adjustment As Restated Debenture conversions $ 114,040 $ 12,522 $ 126,562

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Financial Instruments at Fair Value	The following table is a summary of our financial instruments measured at fair value: Schedule of Financial Instruments at Fair Value Fair Value Measurements as of September 30, 2022: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable and preferred stock $ - $ - $ 3,036,614 $ 3,036,614 $ - $ - $ 3,036,614 $ 3,036,614 Fair Value Measurements as of December 31, 2021: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,398,127 $ 1,398,127 $ - $ - $ 1,398,127 $ 1,398,127
Schedule of Anti-dilutive Securities Excluded from Diluted Net Loss	Schedule of Anti-dilutive Securities Excluded from Diluted Net Loss 2022 2021 Nine Months Ended September 30, 2022 2021 Stock options outstanding - 1,800,000 Warrants 28,333,333 204,946,057 Shares to be issued upon conversion of notes 9,726,808,810 203,651,096 Series D preferred stock 2,010,000,000 67,826 Anti-dilutive securities 11,765,142,143 410,464,979

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable and Convertible Debentures Activity	The following is a summary of the activity of the convertible notes payable and convertible debenture for the nine months ended September 30, 2022: Schedule of Convertible Notes Payable and Convertible Debentures Activity Convertible Debenture Balance as of December 31, 2021 $ 2,195,145 Convertible debenture - debt discount (213,932 ) Additional principal per default provisions 374,125 Amortization of debt discount and original issue discount 158,690 Conversion to common stock, net of discount (99,000 ) Balance as of September 30, 2022 $ 2,415,028
Schedule of Convertible Debenture Outstanding	The following comprises the balance of the convertible debenture outstanding at September 30, 2022 and December 31, 2021: Schedule of Convertible Debenture Outstanding September 30, December 31, 2022 2021 Principal amount outstanding $ 2,496,152 $ 2,221,027 Less: Unamortized original issue discount (79,962 ) - Less: Unamortized original issue discount (1,162 ) (25,882 ) Total $ 2,415,028 $ 2,195,145

Derivative Liability (Tables)

Derivative Liability (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Conversion Feature of Derivative Liability	Schedule of Conversion Feature of Derivative Liability Nine months Ended September 30, 2022 2021 Risk-free interest rate 2.01 % 0.09 % Expected term (in years) 0.48 1 Expected volatility 154.5 % 237.4 % Expected dividend yield 0 % 0 % Exercise price of underlying common shares $ 0.001 $ 0.004
Schedule of Derivative Liability Activity	The following is a summary of the activity of the derivative liability for the nine months ended September 30, 2022: Schedule of Derivative Liability Activity Debenture Balance as of December 31, 2021 $ 1,398,127 Initial fair value per derivative recognition 294,124 Conversion of debenture to common stock (127,397 ) Change in fair value of derivative liability 1,471,760 Balance as of September 30, 2022 $ 3,036,614

Schedule of Restatement of Comp

Schedule of Restatement of Company’s Financial Statements (Details) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash	$ 9,387	$ 12,934		$ 12,934	$ 9,387		$ 78,348
Total assets	51,556	61,551		61,551	51,556		138,516
Accounts payable	1,549,593	1,408,776		1,408,776	1,549,593		985,917
Accrued salaries and consulting fees	743,321	723,007		723,007	743,321		660,331
Derivative liability on convertible notes payable	3,036,614	2,781,435		2,781,435	3,036,614		1,398,127
Total liabilities	10,780,170	10,276,640		10,276,640	10,780,170		6,008,459
Common stock	1,244,213	1,132,010		1,132,010	1,244,213		832,719
Additional paid-in capital	12,549,666	12,549,667		12,549,667	12,549,666		13,215,129
Accumulated deficit	(24,522,546)	(23,896,819)		(23,896,819)	(24,522,546)		(19,917,844)
Total stockholders’ equity (deficit)		(10,215,089)		(10,215,089)
Total liabilities and stockholders’ equity (deficit)	51,556	61,551		61,551	51,556		$ 138,516
General and administrative	12,921		$ 30,727	51,345	64,266	$ 87,241
Total operating expenses	157,752		596,886	731,866	889,618	2,426,067
Interest expense	(149,439)		(437,528)	(1,525,750)	(1,675,189)	(1,726,856)
Change in derivative liability	(318,536)		1,422,551	(1,153,224)	(1,471,760)	(823,425)
Net loss	$ (625,727)		$ 381,062	(3,410,840)	(4,036,567)	(4,983,424)
Net cash used in operating activities				(235,414)	(268,961)	(1,086,128)
Debenture conversions		126,562			$ 238,764
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash		11,269		11,269
Total assets		59,886		59,886
Accounts payable		1,386,797		1,386,797
Accrued salaries and consulting fees		743,321		743,321
Derivative liability on convertible notes payable		2,769,066		2,769,066
Total liabilities		10,262,606		10,262,606
Common stock		1,132,007		1,132,007
Additional paid-in capital		12,549,666		12,549,666
Accumulated deficit		(23,884,446)		(23,884,446)
Total stockholders’ equity (deficit)		(10,202,720)		(10,202,720)
Total liabilities and stockholders’ equity (deficit)		59,886		59,886
General and administrative				39,453
Total operating expenses				719,974
Interest expense				(1,525,116)
Change in derivative liability				(1,105,465)
Net loss				(3,350,555)
Net cash used in operating activities				(237,079)
Debenture conversions		114,040
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash		1,665		1,665
Total assets		1,665		1,665
Accounts payable		21,979		21,979
Accrued salaries and consulting fees		(20,314)		(20,314)
Derivative liability on convertible notes payable		12,369		12,369
Total liabilities		14,034		14,034
Common stock		3		3
Additional paid-in capital		1		1
Accumulated deficit		(12,373)		(12,373)
Total stockholders’ equity (deficit)		(12,369)		(12,369)
Total liabilities and stockholders’ equity (deficit)		1,665		1,665
General and administrative				11,892
Total operating expenses				11,892
Interest expense				(634)
Change in derivative liability				(47,759)
Net loss				(60,285)
Net cash used in operating activities				$ 1,665
Debenture conversions		$ 12,522

Schedule of Financial Instrumen

Schedule of Financial Instruments at Fair Value (Details) - USD ($)	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Derivative liability on convertible notes payable	$ 3,036,614	$ 2,781,435	$ 1,398,127
Derivative instruments at fair value	3,036,614		1,398,127
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Derivative liability on convertible notes payable	3,036,614		1,398,127
Derivative instruments at fair value	$ 3,036,614		$ 1,398,127

Schedule of Anti-dilutive Secur

Schedule of Anti-dilutive Securities Excluded from Diluted Net Loss (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	11,765,142,143	410,464,979
Stock Option Outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities		1,800,000
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	28,333,333	204,946,057
Shares to be Issued upon Conversion of Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	9,726,808,810	203,651,096
Series D Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	2,010,000,000	67,826

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Retained earnings accumulated deficit	$ 24,522,546	$ 23,896,819	$ 19,917,844
Working capital	$ 10,762,513

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Finite lived intangible assets, net	$ 33,899		$ 53,243
Amortization of intangible assets	$ 19,344	$ 19,344

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Apr. 30, 2022	Dec. 31, 2019	Dec. 31, 2019	Sep. 30, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Debt instrument interest rate				2%	2%
Net proceeds loan payable	$ 100,000
Loans payable	$ 130,000
Note Payable [Member]
Short-Term Debt [Line Items]
Note payable outsanding				$ 1,986	$ 1,986
Debt instrument interest rate				2%	2%
Promissory Note [Member]
Short-Term Debt [Line Items]
Net proceeds loan payable			$ 50,000
Note original issue of discount		$ 2,500	$ 2,500
Promissory Note [Member] | Pride Partners LLC [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate		10%	10%
Net proceeds loan payable		$ 75,000

Schedule of Convertible Notes P

Schedule of Convertible Notes Payable and Convertible Debentures Activity (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Short-Term Debt [Line Items]
Beginning balance	$ 2,195,145
Amortization of debt discount and original issue discount	158,690	$ 1,077,708
Ending balance	2,415,028
Debenture [Member]
Short-Term Debt [Line Items]
Beginning balance	2,195,145
Convertible debenture - debt discount	(213,932)
Additional principal per default provisions	374,125
Amortization of debt discount and original issue discount	158,690
Conversion to common stock, net of discount	(99,000)
Ending balance	$ 2,415,028

Schedule of Convertible Debentu

Schedule of Convertible Debenture Outstanding (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Principal amount outstanding	$ 2,496,152	$ 2,221,027
Less: Unamortized original issue discount	(79,962)
Less: Unamortized original issue discount	(1,162)	(25,882)
Total	$ 2,415,028	$ 2,195,145

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Short-Term Debt [Line Items]
Amortization of debt discount and original issue discount					$ 158,690	$ 1,077,708
Provision for doubtful debt		$ 374,125
Interest expense	$ 149,439		$ 437,528	$ 1,525,750	1,675,189	1,726,856
Debt principal amount	2,496,152				2,496,152		$ 2,221,027
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Interest expense		$ 374,125
Securities Purchase Agreement [Member] | Sixth Street Lending LLC [Member]
Short-Term Debt [Line Items]
Amortization of debt discount and original issue discount					158,690	$ 1,077,708
Securities Purchase Agreement [Member] | EMA Financial, LLC [Member]
Short-Term Debt [Line Items]
Debt principal amount	$ 434,687				$ 434,687		$ 434,687
Stock issued during period shares conversion of units							60,714,000

Schedule of Conversion Feature

Schedule of Conversion Feature of Derivative Liability (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares	Sep. 30, 2021 $ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price of underlying common shares	$ 0.001	$ 0.004
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	2.01	0.09
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input, term	5 months 23 days	1 year
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	154.5	237.4
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0	0

Schedule of Derivative Liabilit

Schedule of Derivative Liability Activity (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Balance as of December 31, 2021	$ 1,398,127
Balance as of September 30, 2022	3,036,614
Debenture [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Balance as of December 31, 2021	1,398,127
Initial fair value per derivative recognition	294,124
Conversion of debenture to common stock	(127,397)
Change in fair value of derivative liability	1,471,760
Balance as of September 30, 2022	$ 3,036,614

Preferred Stock (Details Narrat

Preferred Stock (Details Narrative) - USD ($)							1 Months Ended	3 Months Ended			6 Months Ended	9 Months Ended
	Jun. 30, 2022	Jan. 31, 2022	Aug. 20, 2021	Jul. 14, 2021	May 12, 2021	Apr. 08, 2021	Mar. 31, 2021	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Class of Stock [Line Items]
Number of common stock issue							140,000,000
Warrant exercise price								$ 0.01				$ 0.01		$ 0.02
Conversion price	$ 0.0006	$ 0.0015
Fixed conversion price	$ 0.008109	$ 0.008109
Serie d prefrred stock								$ 1,758,224				$ 1,758,224
Reclassified series d prefrred stock												1,015,999
Interest expense								149,439		$ 437,528	$ 1,525,750	1,675,189	$ 1,726,856
Convertible [Member]
Class of Stock [Line Items]
Dividends	$ 285,342	$ 237,924
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock						$ 427,600
Warrant issued						40,000,000
Warrant exercise price						$ 0.001
Preferred stock value								$ 1				$ 1
Preferred Stock shares outstanding								986				986		1,050
Dividends payable								$ 97,814				$ 97,814		$ 52,944
Serie d prefrred stock									$ 1,758,224
Interest expense									644,411
Series D Preferred Stock [Member] | Additional Paid-in Capital [Member]
Class of Stock [Line Items]
Reclassified series d prefrred stock									$ 1,015,999
Series D Preferred Stock [Member] | GHS Investments, LLC [Member]
Class of Stock [Line Items]
Number of common stock issue			250	250	150	400
Proceeds from issuance of convertible preferred stock			$ 250,000	$ 237,500	$ 146,500
Warrant issued					1,500,000
Warrant exercise price					$ 0.001
Conversion of shares	19	45									19
Preferred stock value	$ 22,800	$ 54,000									$ 22,800
Prefered stock convertible shares	38,000,000	36,000,000									38,000,000
Conversion price per share	$ 0.0006	$ 0.0015									$ 0.0006

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)							1 Months Ended		3 Months Ended					6 Months Ended	9 Months Ended
	Jun. 30, 2022	Jan. 31, 2022	Aug. 20, 2021	Jul. 14, 2021	May 12, 2021	Apr. 08, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Class of Stock [Line Items]
Converted value															$ 111,000
Number of common stock issue								140,000,000
Personnel costs									$ 27,852			$ 132,097			$ 188,253	$ 1,521,218
Debentures [Member]
Class of Stock [Line Items]
Debt conversion, shares issued															196,527,778	137,987,777
Debt conversion, shares issued value															$ 99,000	$ 495,247
Board Members [Member]
Class of Stock [Line Items]
Number of common stock issue								140,000,000
Personnel costs								$ 961,666
Employees and Consultants [Member]
Class of Stock [Line Items]
Number of common stock issue							11,956,004	31,834,386
Number of common stock issue, value							$ 204,364	$ 236,448
Common Stock [Member]
Class of Stock [Line Items]
Shares issued for exercise of warrants										97,617,300	43,349,000	30,887,275	30,887,276
Auctus [Member]
Class of Stock [Line Items]
Warrants exercised															140,966,300
Shares issued for exercise of warrants														32,142,857
Series D Preferred Stock [Member] | GHS Investments, LLC [Member]
Class of Stock [Line Items]
Preferred stock shares issuable	38,000,000	36,000,000								38,000,000
Converted value	$ 57,000	$ 54,000
Preferred stock, convertible, conversion price	$ 0.0006	$ 0.0015								$ 0.0006
Number of common stock issue			250	250	150	400
Series D Preferred Stock [Member] | GHS Investments, LLC [Member] | Common Stock [Member]
Class of Stock [Line Items]
Preferred stock shares issuable	19	45								19
Series C Preferred Stock [Member] | Pride [Member]
Class of Stock [Line Items]
Number of shares converted																53,000
Conversion of stock, shares issued																53,000,000

Options and Warrants (Details N

Options and Warrants (Details Narrative) - $ / shares	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding	28,333,333	174,058,782
Warrant exercise price	$ 0.01	$ 0.02
Auctus [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Exercise of warrants, shares	140,966,300
Two Thousand Twelve Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding	0	0

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Feb. 28, 2022
Related Party Transaction [Line Items]
Notes payable to related party		$ 1,800		$ 1,800		$ 1,800	$ 70,000
Interest rate		2%		2%		2%
Common shares issued for cash, shares	140,000,000
Personnel costs		$ 27,852	$ 132,097	$ 188,253	$ 1,521,218
Conversion of accrued consulting fees into common shares					338,608
Fund expenses				100,000
Other receivables		0		0
Procure AMLLC [Member]
Related Party Transaction [Line Items]
Receivables, net, current						$ 100,000
Custodian [Member]
Related Party Transaction [Line Items]
Receivables, net, current						305,000
Fund expenses				100,000		305,000
Officers and Executive Director [Member]
Related Party Transaction [Line Items]
Accrued salaries		522,804		522,804		472,804
Chief Operating Officer [Member]
Related Party Transaction [Line Items]
Common shares issued for cash, shares	200,000,000
Number of shares issued, value	$ 160,000
Seven Board Members [Member]
Related Party Transaction [Line Items]
Common shares issued for cash, shares	20,000,000
Personnel costs	$ 961,666
Conversion of accrued consulting fees into common shares	$ 138,334
Officers And Board Members [Member]
Related Party Transaction [Line Items]
Accounts payable to related parties		$ 168,308		$ 168,308		$ 102,808

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Oct. 05, 2022 shares
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock return back	64,322,748